MPZ and cerebellar ataxia: Clinical disease activity status, however, improvement upon IVIg-treatment, or clinical features such as tremor and ataxia were independent of T cell reaction specific to NF155, NF186, P0 180–199, or MBP 82–100 (Table 2).